Gen2 Biofuels: Despite Growing Pains, Billion-Gallon Milestone Within Reach

Biofuels Digest
Jim Lane November 14, 2011

Cellulosic biofuels are behind schedule. Can they catch up? What are the barriers, the roles to be played by Washington, developers alike? What are the opportunities for the retail investor?

A downloadable report from Pavel Molchanov and Raymond James assesses the space.

In California, Raymond James renewable energy analyst Pavel Molchanov released a foundational report on Gen2 advanced biofuels this past week, on the eve of the Advanced Biofuels Markets conference which concluded last Thursday.

“Amid volatile commodity and equity markets, and despite some growing pains along the way, the industry continues to develop,” Molchanov writes. “We expect 2012 to be a critical period as a wide variety of Gen2 biofuels approach commercialization, and companies increasingly “graduate” from the pre-revenue stage to full commercial operations.”

Read more and link to the report